Pharmacological characterization of α-elapitoxin-Al2a from the venom of the Australian pygmy copperhead (Austrelaps labialis): An atypical long-chain α-neurotoxin with only weak affinity for α7 nicotinic receptors
Francesca Marcon, Graham M. Nicholson(University of Technology Sydney), Irina Vetter(Centre National de la Recherche Scientifique), Mathieu Leblanc, Richard J. Lewis(AstraZeneca (Netherlands)), Pierre Escoubas(Fondation Sophia Antipolis)
Cited by 13
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422